965 related articles for article (PubMed ID: 18471463)
1. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
2. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
[TBL] [Abstract][Full Text] [Related]
4. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
[TBL] [Abstract][Full Text] [Related]
5. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
6. Recurrent events after percutaneous closure of patent foramen ovale.
Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
[TBL] [Abstract][Full Text] [Related]
7. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial.
Hong TE; Thaler D; Brorson J; Heitschmidt M; Hijazi ZM;
Catheter Cardiovasc Interv; 2003 Dec; 60(4):524-8. PubMed ID: 14624434
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N
Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
Harms V; Reisman M; Fuller CJ; Spencer MP; Olsen JV; Krabill KA; Gray WA; Jesurum JT
Am J Cardiol; 2007 May; 99(9):1312-5. PubMed ID: 17478164
[TBL] [Abstract][Full Text] [Related]
12. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry.
Alameddine F; Block PC
Catheter Cardiovasc Interv; 2004 Aug; 62(4):512-6. PubMed ID: 15274163
[TBL] [Abstract][Full Text] [Related]
14. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF
JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618
[TBL] [Abstract][Full Text] [Related]
15. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
Wahl A; Kunz M; Moschovitis A; Nageh T; Schwerzmann M; Seiler C; Mattle HP; Windecker S; Meier B
Heart; 2008 Mar; 94(3):336-41. PubMed ID: 17639093
[TBL] [Abstract][Full Text] [Related]
16. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
Wahl A; Jüni P; Mono ML; Kalesan B; Praz F; Geister L; Räber L; Nedeltchev K; Mattle HP; Windecker S; Meier B
Circulation; 2012 Feb; 125(6):803-12. PubMed ID: 22238228
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873
[TBL] [Abstract][Full Text] [Related]
18. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
[TBL] [Abstract][Full Text] [Related]
19. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.
Silverman IE; Kiernan FJ; Kelsey AM; Brakoniecki JJ; Kazi FA; Dougherty JE; Boden WE; McKay RG
Conn Med; 2003 Mar; 67(3):135-44. PubMed ID: 12687787
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems.
Braun M; Gliech V; Boscheri A; Schoen S; Gahn G; Reichmann H; Haass M; Schraeder R; Strasser RH
Eur Heart J; 2004 Mar; 25(5):424-30. PubMed ID: 15033255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]